Leadership Change at Genetic Signatures Limited
Filed with ASX · · 1 page · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Limited [ASX:GSS] (“GSS” or the “Company”), a global molecular diagnostics company, advises that its Chief Executive Officer (“CEO”), Ms Allison Rossiter, has informed the Board that she will be leaving Genetic Signatures in late February 2026 to take on a role with a global pharmaceutical company. The Board is initiating a search for a CEO to replace Ms Rossiter, and will imple
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- $4.4m R&D Tax Incentive Received
- 2025 Annual General Meeting Chair Address & Presentation
- FY25 Market Update
- FY25 Results Release
- FY25 Appendix 4E and Annual Report
Later from Genetic Signatures
- Quarterly Activities/Appendix 4C Cash Flow Report
- Genetic Signatures Appoints Maria Halasz as CEO
- GSS Appoints Anne Lockwood as Interim Managing Director
- 1H FY26 Appendix 4D and Half Year Report
- 1H FY26 Results Presentation
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures